0299-6220Level 3
NEMLUVIO (nemolizumab-ilto)
**Product type:** Human Prescription Drug
**Active ingredient:** NEMOLIZUMAB
**Strength:** 30 mg/100mg
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Subcutaneous
**Labeler:** Galderma Laboratories, L.P.
**Marketing category:** BLA (BLA761390)
**Pharmacologic class:** Interleukin-31 Receptor alpha Antagonist [EPC], Interleukin-31 Receptor alpha Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0299-6220Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.